State Of Alaska, Department Of Revenue Biocryst Pharmaceuticals Inc Transaction History
State Of Alaska, Department Of Revenue
- $9.79 Billion
- Q3 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 11,899 shares of BCRX stock, worth $86,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,899Holding current value
$86,267% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
314Shares Held
201MCall Options Held
930KPut Options Held
553K-
Vanguard Group Inc Valley Forge, PA20.5MShares$149 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$145 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$61.7 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.46MShares$61.4 Million9.06% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$41.4 Million0.09% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.35B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...